Stock Track | Pfizer Plummets 5.11% Intraday as 2026 Profit Forecast Misses Estimates

Stock Track12-16 23:38

Pfizer's stock (PFE) plummeted 5.11% during intraday trading on Tuesday after the company issued a weaker-than-expected profit forecast for 2026, disappointing investors.

The drugmaker projected adjusted earnings per share of $2.80 to $3 for 2026, below analysts' average estimate of $3.05. Revenue is expected to range between $59.5 billion and $62.5 billion, also missing consensus estimates. The guidance reflects a $1.5 billion decline in COVID-19 product sales and another $1.5 billion hit from the loss of exclusivity on older drugs.

Pfizer also revised its 2025 revenue forecast to approximately $62 billion, down from its earlier range of $61 billion to $64 billion. The company is working to cut costs and streamline its business, but the weak outlook overshadowed these efforts.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment